Detalhe da pesquisa
1.
14-day tailored PCR-guided triple therapy versus 14-day non-Bismuth concomitant quadruple therapy for Helicobacter pylori eradication: A multicenter, open-label randomized noninferiority controlled trial.
Helicobacter
; 29(2): e13076, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38680067